Abstract
Purpose
To study the impact of pre-morbid glycemic control on the association between acute hypoglycemia in intensive care unit (ICU) patients and subsequent hospital mortality in critically ill patients.
Methods
We performed a multicenter, multinational, retrospective observational study of patients with available HbA1c levels within the 3-month period preceding ICU admission. We separated patients into three cohorts according to pre-admission HbA1c levels (<6.5, 6.5–7.9, ≥8.0 %, respectively). Based on published data, we defined a glucose concentration of 40–69 mg/dL (2.2–3.8 mmol/L) as moderate hypoglycemia and <40 mg/dL (<2.2 mmol/L) as severe hypoglycemia. We applied logistic regression analysis to study the impact of pre-morbid glycemic control on the relationship between acute hypoglycemia and mortality.
Results
A total of 3084 critically ill patients were enrolled in the study. Among these patients, with increasing HbA1c levels from <6.5, to 6.5–7.9, and to ≥8.0 %, the incidence of both moderate (3.8, 11.1, and 16.4 %, respectively; p < 0.001) and severe (0.9, 2.5, and 4.3 %, respectively; p < 0.001) hypoglycemia progressively and significantly increased. The relationship between the occurrence of hypoglycemic episodes in the ICU and in-hospital mortality was independently and significantly affected by pre-morbid glucose control, as assessed by adjusted odds ratio (OR) and 95 % confidence interval (CI) for hospital mortality: (1) moderate hypoglycemia: in patients with <6.5, 6.5–7.9, and ≥8.0 % of HbA1c level—OR 0.54, 95 % CI 0.25–1.16; OR 0.82, 95 % CI 0.33–2.05; OR 3.42, 95 % CI 1.29–9.06, respectively; (2) severe hypoglycemia: OR 1.50, 95 % CI 0.42–5.33; OR 1.59, 95 % CI 0.36–7.10; OR 23.46, 95 % CI 5.13–107.28, respectively (interaction with pre-morbid glucose control, p = 0.009). We found that the higher the glucose level before admission to the ICU, the higher the mortality risk when patients experienced hypoglycemia.
Conclusions
In critically ill patients, chronic pre-morbid hyperglycemia increases the risk of hypoglycemia and modifies the association between acute hypoglycemia and mortality.
Similar content being viewed by others
References
Jacobi J, Bircher N, Krinsley J, Agus M, Braithwaite S, Deutschman C, Freire A, Geehan D, Kohl B, Nasraway S, Rigby M, Sands K, Schallom L, Taylor B, Umpierrez G, Mazuski J, Schunemann H (2012) Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Crit Care Med 40:3251–3276
Egi M, Bellomo R, Stachowski E, French CJ, Hart GK, Taori G, Hegarty C, Bailey M (2010) Hypoglycemia and outcome in critically ill patients. Mayo Clin Proc 85:217–224
Finfer S, Liu B, Chittock DR, Norton R, Myburgh JA, McArthur C, Mitchell I, Foster D, Dhingra V, Henderson WR, Ronco JJ, Bellomo R, Cook D, McDonald E, Dodek P, Hebert PC, Heyland DK, Robinson BG (2012) Hypoglycemia and risk of death in critically ill patients. N Engl J Med 367:1108–1118
Sonneville R, Vanhorebeek I, den Hertog HM, Chretien F, Annane D, Sharshar T, Van den Berghe G (2015) Critical illness-induced dysglycemia and the brain. Intensive Care Med 41:192–202
Widom B, Simonson DC (1990) Glycemic control and neuropsychologic function during hypoglycemia in patients with insulin-dependent diabetes mellitus. Ann Intern Med 112:904–912
Marik PE, Egi M (2014) Treatment thresholds for hyperglycemia in critically ill patients with and without diabetes. Intensive Care Med 40:1049–1051
Saudek CD, Derr RL, Kalyani RR (2006) Assessing glycemia in diabetes using self-monitoring blood glucose and hemoglobin A1c. JAMA 295:1688–1697
Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13:818–829
International Expert Committee (2009) International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32:1327–1334
UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352: 837–853
Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hebert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ (2009) Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360:1283–1297
Finfer S, Chittock D, Li Y, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Hebert P, Henderson W, Heyland D, Higgins A, McArthur C, Mitchell I, Myburgh J, Robinson B, Ronco J (2015) Intensive versus conventional glucose control in critically ill patients with traumatic brain injury: long-term follow-up of a subgroup of patients from the NICE-SUGAR study. Intensive Care Med 41:1037–1047
Egi M, Bellomo R, Stachowski E, French CJ, Hart G (2006) Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 105:244–252
Egi M, Bellomo R, Stachowski E, French CJ, Hart GK, Taori G, Hegarty C, Bailey M (2011) The interaction of chronic and acute glycemia with mortality in critically ill patients with diabetes. Crit Care Med 39:105–111
Plummer MP, Bellomo R, Cousins CE, Annink CE, Sundararajan K, Reddi BA, Raj JP, Chapman MJ, Horowitz M, Deane AM (2014) Dysglycaemia in the critically ill and the interaction of chronic and acute glycaemia with mortality. Intensive Care Med 40:973–980
Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH Jr, Probstfield JL, Simons-Morton DG, Friedewald WT (2008) Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358:2545–2559
Hempe JM, Liu S, Myers L, McCarter RJ, Buse JB, Fonseca V (2015) The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD trial. Diabetes Care 38:1067–1074
Krinsley JS, Grover A (2007) Severe hypoglycemia in critically ill patients: risk factors and outcomes. Crit Care Med 35:2262–2267
Vriesendorp TM, van Santen S, DeVries JH, de Jonge E, Rosendaal FR, Schultz MJ, Hoekstra JB (2006) Predisposing factors for hypoglycemia in the intensive care unit. Crit Care Med 34:96–101
Miller ME, Bonds DE, Gerstein HC, Seaquist ER, Bergenstal RM, Calles-Escandon J, Childress RD, Craven TE, Cuddihy RM, Dailey G, Feinglos MN, Ismail-Beigi F, Largay JF, O’Connor PJ, Paul T, Savage PJ, Schubart UK, Sood A, Genuth S (2010) The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study. BMJ 340:b5444
Dotson S, Freeman R, Failing HJ, Adler GK (2008) Hypoglycemia increases serum interleukin-6 levels in healthy men and women. Diabetes Care 31:1222–1223
Schlenk F, Graetz D, Nagel A, Schmidt M, Sarrafzadeh AS (2008) Insulin-related decrease in cerebral glucose despite normoglycemia in aneurysmal subarachnoid hemorrhage. Crit Care 12:R9
Herlein JA, Morgan DA, Phillips BG, Haynes WG, Sivitz WI (2006) Antecedent hypoglycemia, catecholamine depletion, and subsequent sympathetic neural responses. Endocrinology 147:2781–2788
Dieguez G, Fernandez N, Garcia JL, Garcia-Villalon AL, Monge L, Gomez B (1997) Role of nitric oxide in the effects of hypoglycemia on the cerebral circulation in awake goats. Eur J Pharmacol 330:185–193
Lin SH, Chau T, Wu CC, Yang SS (2002) Osmotic demyelination syndrome after correction of chronic hyponatremia with normal saline. Am J Med Sci 323:259–262
Pokaharel M, Block CA Dysnatremia in the ICU. Curr Opin Crit Care 17:581–593
Webster NR, Kulkarni V (1999) Metabolic alkalosis in the critically ill. Crit Rev Clin Lab Sci 36:497–510
Sun Q, Li J, Gao F (2014) New insights into insulin: the anti-inflammatory effect and its clinical relevance. World J Diabetes 5:89–96
Arabi YM, Tamim HM, Rishu AH (2009) Hypoglycemia with intensive insulin therapy in critically ill patients: predisposing factors and association with mortality. Crit Care Med 37:2536–2544
Sprague JE, Arbelaez AM (2011) Glucose counter regulatory responses to hypoglycemia. Pediatr Endocrinol Rev 9:463–473 (Quiz 474–465)
Cryer PE (2005) Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes. Diabetes 54:3592–3601
Segel SA, Paramore DS, Cryer PE (2002) Hypoglycemia-associated autonomic failure in advanced type 2 diabetes. Diabetes 51:724–733
Egi M, Bellomo R, Stachowski E, French CJ, Hart GK, Hegarty C, Bailey M (2008) Blood glucose concentration and outcome of critical illness: the impact of diabetes. Crit Care Med 36:2249–2255
Krinsley JS, Meyfroidt G, van den Berghe G, Egi M, Bellomo R (2012) The impact of premorbid diabetic status on the relationship between the three domains of glycemic control and mortality in critically ill patients. Curr Opin Clin Nutr Metab Care 15:151–160
Lanspa MJ, Hirshberg EL, Phillips GD, Holmen J, Stoddard G, Orme J (2013) Moderate glucose control is associated with increased mortality compared to tight glucose control in critically ill patients without diabetics. Chest 143(5):1226–1234
Krinsley JS, Egi M, Kiss A, Amin DN, Schuetz P, Maurer PM, Schultz MJ, van Hooijdonk RT, Kiyoshi M, Mackenzie IM, Annane D, Stow P, Nasraway SA, Holewinski S, Holzinger U, Preiser JC, Vincent JL, Bellomo R (2013) Diabetic status and the relationship of the 3 domains of glycemic control to mortality in critically ill patients: an international multi-center cohort study. Crit Care 17:R37
Greenfield S, Billimek J, Pellegrini F, Franciosi M, De Berardis G, Nicolucci A, Kaplan SH (2009) Comorbidity affects the relationship between glycemic control and cardiovascular outcomes in diabetes: a cohort study. Ann Intern Med 151:854–860
Falciglia M, Freyberg RW, Almenoff PL, D’Alessio DA, Render ML (2009) Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit Care Med 37:3001–3009
Mitsios JV, Ashby LA, Haverstick DM, Bruns DE, Scott MG (2013) Analytic evaluation of a new glucose meter system in 15 different critical care settings. J Diabetes Sci Technol 7:1282–1287
Nanayakkara N, Nguyen H, Churilov L, Kong A, Pang N, Hart GK, Owen-Jones E, White J, Ross J, Stevenson V, Bellomo R, Lam Q, Crinis N, Robbins R, Johnson D, Baker ST, Zajac JD, Ekinci EI (2015) Inpatient HbA1c testing: a prospective observational study. BMJ Open Diabetes Res Care 3:e000113
Hill AB (1965) The environment and disease: association or causation? Proc R Soc Med 58:295–300
Acknowledgments
This study was supported by the grants-in-aid for scientific research from the Ministry of Education, Science, and Culture of Japan.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
Drs. Egi, Kanazawa, Morita, Bailey, Amin, Bellomo report no relevant disclosures. Dr. Krinsley reports receiving consultant fees from Medtronic Inc., Edwards Life Sciences, Roche Diagnostics, OptiScan Biomedical, and Alere and research support from OptiScan Biomedical. He also received royalty payments for sales of the ICU Tracker. Ms. Maurer works as a consultant for Alere, the distributor of ICU Tracker.
Additional information
Take-home message: Critically ill patients with higher pre-admission HbA1c levels were at significantly greater risk of hypoglycemia while in ICU. More importantly, the higher the degree of chronic hyperglycemia before ICU admission, the higher the hospital mortality among those patients who experienced hypoglycemia while in ICU.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Egi, M., Krinsley, J.S., Maurer, P. et al. Pre-morbid glycemic control modifies the interaction between acute hypoglycemia and mortality. Intensive Care Med 42, 562–571 (2016). https://doi.org/10.1007/s00134-016-4216-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-016-4216-8